Newsroom | 3078 results
Sorted by: Latest
-
The Veterinary Cooperative and Elanco Donate $14,088 to The Street Dog Coalition
EVANSTON, Ill.--(BUSINESS WIRE)--The Veterinary Cooperative (TVC), a member-owned cooperative supporting independent veterinary practices across the United States, today announced a combined $14,088 donation to The Street Dog Coalition following its Paws for a Cause: Bingo Night fundraiser at TVC VetVision™ 2026. TVC raised $7,044 during the event, with Elanco Animal Health matching the contribution dollar for dollar. The Street Dog Coalition provides free veterinary care to pets of people expe...
-
Zoetis Declares Fourth Quarter 2026 Dividend
PARSIPPANY, N.J.--(BUSINESS WIRE)--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.53 per share for the fourth quarter of 2026. The dividend will be paid on Tuesday, December 1, 2026, to all holders of record of the Company’s common stock as of the close of business on Friday, October 30, 2026. About Zoetis Zoetis is the world’s leading animal health company, driven by a singular purpose: to nurture our world and humankind by advancing care for animals. With a leg...
-
PetPace Announces Launch at Chewy, Bringing Advanced AI-Powered Pet Health Monitoring to Millions of Pet Parents
BURLINGTON, Mass.--(BUSINESS WIRE)--PetPace, the leader in AI-powered wearable pet health technology, today announced that its award-winning PetPace Smart Health Monitoring Collar is now available at Chewy, a trusted destination for pet parents and partners, everywhere. PetPace’s groundbreaking technology gives dog and cat owners unprecedented access to continuous health monitoring and actionable insights designed to help them recognize changes in their pets’ health sooner. Unlike traditional a...
-
New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus1
PARSIPPANY, N.J.--(BUSINESS WIRE)--Drug-resistant heartworm is a growing concern for veterinarians and pet owners as resistant heartworm populations emerge. New research shows that not all heartworm preventives perform equally against these resistant isolates. Macrocyclic lactone (ML) resistance means some heartworm isolates are less sensitive to the drug class used in today’s heartworm disease preventives. As ML resistance continues to challenge heartworm prevention, veterinarians need data th...
-
Antech™ Introduces trūRapid™ Reader in North America to Support trūRapid Portfolio
LOVELAND, Colo.--(BUSINESS WIRE)--Antech launches the trūRapid™ Reader, a portable device that captures a timed image of the result for the trūRapid line of in-house screening tests....
-
Novel Takes Veterinary Care Beyond the Clinic Through Partnership with Airvet
BURLINGTON, Ontario--(BUSINESS WIRE)--Novel, the Ontario-based companion animal veterinary company has partnered with Airvet, becoming Airvet’s first Canadian veterinary partner....
-
Cronus Pharma Announces the Launch of Florfinasone™ Otic for the Treatment of Otitis Externa in Dogs
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Cronus Pharma LLC, a fully integrated animal health company, today announced the launch of Florfinasone Otic (florfenicol, terbinafine, mometasone furoate), an FDA-approved product indicated for the treatment of otitis externa in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius). Florfinasone Otic is a fixed-combination therapy that provides antibacterial, antifungal, and anti-inflam...
-
IDEXX Laboratories to Release 2026 Third Quarter Financial Results
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 third quarter financial results for Monday, November 2, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q3 2026 Earnings Snapshot through a link on the IDEXX websi...
-
Wagmo and Wonderdog Partner to Bring Early Disease Detection to Employee Pet Benefits
NEW YORK--(BUSINESS WIRE)--Wagmo and Wonderdog announce a perks partnership adding proactive health intelligence and early disease detection to Wagmo's employee pet benefits....
-
Beyond Cellular Models: Longevica Capitalizes on World’s Largest In Vivo Longevity Study to Form Star-Studded Advisory Board and Unlock Human Health-and-Lifespan Pipeline
SAN FRANCISCO & NEW YORK--(BUSINESS WIRE)--Longevica forms a star SAB to turn its $13M, 16k-subject mammalian study into AI-driven drug discovery, pet health, and novel human therapies....